Proinflammatory cytokines and hemofiltration membranes. Goldfarb S, Golper TA (1994) J Am Soc Nephrol 5: 228-32 Development of a hybrid bioartificial liver. Rozga J, Holzman MD, Ro MS, Griffin DW, Neuzil DF, Giorgio T, Moscioni AD, Demetriou AA (1993) Ann Surg 217: 502-9; discussion 509-11 Cell therapy with a tissue-engineered kidney reduces the multiple-organ consequences of septic shock. Humes HD, Buffington DA, Lou L, Abrishami S, Wang M, Xia J, Fissell WH (2003) Crit Care Med 31: 2421-8 Metabolic replacement of kidney function in uremic animals with a bioartificial kidney containing human cells. Humes HD, Fissell WH, Weitzel WF, Buffington DA, Westover AJ, MacKay SM, Gutierrez JM (2002) Am J Kidney Dis 39: 1078-87 Therapeutic drug monitoring of piperacillin-tazobactam using spent dialysate effluent in patients receiving continuous venovenous hemodialysis. Connor MJ, Salem C, Bauer SR, Hofmann CL, Groszek J, Butler R, Rehm SJ, Fissell WH (2011) Antimicrob Agents Chemother 55: 557-60 Biomolecular transport through hemofiltration membranes. Conlisk AT, Datta S, Fissell WH, Roy S (2009) Ann Biomed Eng 37: 722-36 Renal cell therapy in the treatment of patients with acute and chronic renal failure. Humes HD, Weitzel WF, Fissell WH (2004) Blood Purif 22: 60-72 Sieving characteristics of a new polysulfone hemofilter for use with continuous arterio-venous hemofiltration. Kaplan AA, Golper TA (1987) Int J Artif Organs 10: 357-60 First Implantation of Silicon Nanopore Membrane Hemofilters. Kensinger C, Karp S, Kant R, Chui BW, Goldman K, Yeager T, Gould ER, Buck A, Laneve DC, Groszek JJ, Roy S, Fissell WH (2016) ASAIO J 62: 491-5 Middle-molecule clearance in CRRT: in vitro convection, diffusion and dialyzer area. Messer J, Mulcahy B, Fissell WH (2009) ASAIO J 55: 224-6 Silicon induces minimal thromboinflammatory response during 28-day intravascular implant testing. Melvin ME, Fissell WH, Roy S, Brown DL (2010) ASAIO J 56: 344-8 Continuous venovenous hemofiltration for acute renal failure in the intensive care setting. Technical considerations. Golper TA, Price J (1994) ASAIO J 40: 936-9 The role of convection during simulated continuous arteriovenous hemodialysis. Golper TA, Cigarran-Guldris S, Jenkins RD, Brier ME (1991) Contrib Nephrol 93: 146-8 Tobramycin clearance during simulated continuous arteriovenous hemodialysis. Cigarran-Guldris S, Brier ME, Golper TA (1991) Contrib Nephrol 93: 120-3 Drug removal during continuous hemofiltration or hemodialysis. Golper TA (1991) Contrib Nephrol 93: 110-6 Hybrid renal replacement modalities for the critically ill. Marshall MR, Golper TA, Shaver MJ, Chatoth DK (2001) Contrib Nephrol : 252-7 Update on drug sieving coefficients and dosing adjustments during continuous renal replacement therapies. Golper TA (2001) Contrib Nephrol : 349-53
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.